Pharmaceutical blockade of the neonatal Fc receptor (FcRn) ameliorates autoimmunity, inflammation, and fibrosis in the antitopoisomerase-I antibody-driven mouse model of systemic sclerosis
Study Overview The investigation centers on evaluating the effects of targeted pharmaceutical intervention on the neonatal Fc receptor (FcRn) in […]
